Rivastigmine Tartrate
Product Images NDC 27241-092

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Rivastigmine Tartrate (NDC 27241-092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Stru (Rivastigmine Structure)

FDA Label Image

Fig1 (Rivastigmine Fig1)

FDA Label Image

Fig2 (Rivastigmine Fig2)

The text appears to be a table showing the Cumulative Percentage of Patients and the Change From Baseline for different treatments. The treatments include Changsn ADAS-c0g, 1-4mg Phtebo, Placebo tdmgy, and G2mgdy. The table also shows the dosage for Changsn ADAS-c0g (o-6-12mg) and G2mgdy (117 28). The percentage of patients ranges from 16% to 68%, and the change from baseline ranges from 0 to 25%.*

FDA Label Image

Fig3 (Rivastigmine Fig3)

FDA Label Image

Fig4 (Rivastigmine Fig4)

FDA Label Image

Fig5 (Rivastigmine Fig5)

FDA Label Image

Fig6 (Rivastigmine Fig6)

FDA Label Image

Figure7 (Rivastigmine Fig7)

FDA Label Image

Figure8 (Rivastigmine Fig8)

FDA Label Image

Rivastigmine_1.5_mg (Rivastigmine 1.5 mg 60)

Rivastigmine Tartrate Capsules, USP are a medication containing 1.5 mg of Rivastigmine base which is a cholinesterase inhibitor used in the treatment of dementia. These capsules should be stored at a controlled room temperature and should be kept in a tight container. As with all medications, Rivastigmine Tartrate Capsules should be kept out of the reach of children. Dosage information should be consulted on the package insert. These capsules are marketed by Ajanta Pharma USA Inc. and manufactured by Ajanta Pharma Limited in India. NDC 27241-090-06 contains 60 capsules.*

FDA Label Image

Rivastigmine_3_mg (Rivastigmine 3 mg 60)

Each capsule of this drug contains 3mg of Rivastigmine Tartrate USP equivalent to Rivastigmine base. This medication should be stored in a tight container at a temperature between 15°C to 30°C (59°F to 86°F). The package insert can be consulted for dosage information. It is important to keep this medication away from children. The drug is marketed by Ajanta Pharma USA Inc. located in Bridgewater, NJ 08807 and manufactured by Ajanta Pharma Limited located in Paithan 431 148, India. The NDC number for this drug is 27241-091-06 and it comes in the form of a USP Capsule.*

FDA Label Image

Rivastigmine_4.5_mg (Rivastigmine 4.5 mg 60)

Each capsule of the drug contains 4.5 mg of Rivastigmine Tartrate USP. This drug must be stored at a temperature not exceeding 25°C and within the range of 15°C to 30°C. The recommended way of dispensing is in a tight container that meets the USP tightness requirements. The prescription drug comes with a package insert providing usual dosage and other necessary information. As with all other drugs, Rivastigmine Tartrate Capsules should be kept away from children. It is manufactured by Ajanta Pharma Limited in Paithan, India, and marketed in Bridgewater, NJ, by Ajanta Pharma USA Inc. The medication has an NDC code of 27241-092-06 and an assigned code number of MH/DRUGS/AD/018. However, ajanta 1575705 20 is not a legible text and, therefore, its meaning is uncertain.*

FDA Label Image

Rivastigmine_6_mg (Rivastigmine 6 mg 60)

This is a medication called Rivastigmine in capsule form, containing 6mg of Rivastigmine Tartrate USP. It should be stored in a USP tight container at 25°C, with allowed temperature range of 15°C to 30°C. The recommended dosage information can be found in the package insert. The drug should be kept away from children and is marketed by Ajanta Pharma USA Inc. It is manufactured by Ajanta Pharma Limited in Paithan, India, and the stock keeping unit (SKU) number is P25125.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.